Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, et al
10.1093/hmg/dds302 Hum
While the use of glutathione as a treatment for specific disease states should be based on clinical evidence and under the guidance of a healthcare provider, the sublingual troche formulation offers a unique delivery system that may enhance the effectiveness of glutathione supplementation
What It Is A physician-formulated, chewable liposomal tablet containing: Nanotized, reduced S-acetyl L-glutathione A potent 30 mg per serving for high-dose clinical support Oral liposomal LPT delivery for enhanced absorption and cellular uptake Glutathione LPT is ideal for patients with detoxification challenges, chronic inflammation, or oxidative damage, and for those seeking to enhance immune resilience and promote healthy aging What It Does Supports glutathione replenishment, which is essential for detoxification and cellular defense Promotes immune system regulation and overall resilience Aids in liver detoxification and protection, making it ideal for NAFLD and cirrhosis support for adults Helps to regulate insulin sensitivity and blood sugar metabolism Combats inflammatory and oxidative stress pathways throughout the body Provides neurovascular and cognitive protection (e.g., for Alzheimers, peripheral neuropathies) Supports healthy skin, joints, and connective tissue repair Helps to manage mood, energy levels, and the body's stress response for those Who It's For Glutathione LPT is recommended for: Patients experiencing chronic inflammation, oxidative stress, or detoxification issues Individuals with liver disorders such as NAFLD, cirrhosis, or elevated liver enzymes
Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice
Mucosal samples from TNBS+ethanol-treated rats indicated a direct correlation between GSH depletion and injury detected as soon as 30 minutes after TNBS+ethanol administration that persisted 24 hours post treatment
/assets/images/provider/photos/2813769.png)
